Inventor · disambiguated record
Xianming Deng
Also filed as: DENG XIANMING
30 granted patents·8 pending applications·117 citations·filing 2008–2024
95Inventor score
Files withDANA FARBER CANCER INST INC16UNIV XIAMEN5GRAY NATHANAEL S3HONGYUN BIOTECH CO LTD3XIAMEN VIVOHEALTHS TECH CO LTD3
Top patents by PatentIndex Score
38 records- 0193US9358231B2Type II RAF kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 7, 2016·22 cites·1 claims
- 0293US9180127B2Type II Raf kinase inhibitorsGRAY NATHANAEL S·Filed 2010·Granted Nov 10, 2015·24 cites·8 claims
- 0393US8921336B2Small molecule myristate inhibitors of BCR-ABL and methods of useGRAY NATHANAEL·Filed 2008·Granted Dec 30, 2014·12 cites·10 claims
- 0491US8987275B2Indazole compounds and their usesGRAY NATHANAEL·Filed 2011·Granted Mar 24, 2015·22 cites·28 claims
- 0590US9676792B2Pyrimido-diazepinone compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 13, 2017·12 cites·6 claims
- 0688US9464091B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2016·Granted Oct 11, 2016·5 cites·14 claims
- 0786US11826365B2Type II raf kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2020·Granted Nov 28, 2023·1 cites·8 claims
- 0886US9266890B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersGRAY NATHANAEL S·Filed 2010·Granted Feb 23, 2016·7 cites·3 claims
- 0986US2024158403A1Small molecule myristate inhibitors of bcr-abl and methods of useDANA FARBER CANCER INST INC·Filed 2024·Application pending·0 cites
- 1081US10457692B2Pyrimido-diazepinone compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2018·Granted Oct 29, 2019·2 cites·12 claims
- 1181US10081639B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2017·Granted Sep 25, 2018·2 cites·6 claims
- 1281US9701683B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2016·Granted Jul 11, 2017·2 cites·6 claims
- 1380US10189861B2Pyrimido-diazepinone compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2017·Granted Jan 29, 2019·2 cites·5 claims
- 1479US11932646B2Small molecule myristate inhibitors of Bcr-abl and methods of useDANA FARBER CANCER INST INC·Filed 2022·Granted Mar 19, 2024·0 cites·4 claims
- 1573US11254682B2Small molecule myristate inhibitors of Bcr-abl and methods of useDANA FARBER CANCER INST INC·Filed 2020·Granted Feb 22, 2022·0 cites·18 claims
- 1670US11292787B2Five-membered-fused-six-membered aza-aromatic ring compound, preparation method thereof, pharmaceutical composition and application thereofUNIV XIAMEN·Filed 2018·Granted Apr 5, 2022·1 cites·4 claims
- 1770US9670214B2Small molecule myristate inhibitors of Bcr-abl and methods of useGRAY NATHANAEL S·Filed 2014·Granted Jun 6, 2017·0 cites·5 claims
- 1868US11352354B2Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereofUNIV XIAMEN·Filed 2018·Granted Jun 7, 2022·1 cites·18 claims
- 1967US11414379B2SPAK kinase inhibitors as neuroprotective agentsUS GOV VETERANS AFFAIRS·Filed 2021·Granted Aug 16, 2022·0 cites·20 claims
- 2067US10995061B2SPAK kinase inhibitors as neuroprotective agentsUS GOV VETERANS AFFAIRS·Filed 2019·Granted May 4, 2021·0 cites·18 claims
- 2167US10787455B2Small molecule myristate inhibitors of BCR-ABL and methods of useDANA FARBER CANCER INST INC·Filed 2018·Granted Sep 29, 2020·0 cites·5 claims
- 2267US10570154B2Pyrimido-diazepinone kinase scaffold compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2018·Granted Feb 25, 2020·0 cites·10 claims
- 2367US10508118B2Pyrimidopyrrole compounds, method for preparing the same, pharmaceutical compositions comprising the same and uses thereofUNIV XIAMEN·Filed 2016·Granted Dec 17, 2019·1 cites·15 claims
- 2467US2017349595A1Small molecule myristate inhibitors of bcr-abl and abl and methods of useDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 2564US10787461B2Pyrimido-diazepinone compounds and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2019·Granted Sep 29, 2020·0 cites·12 claims
- 2663US11584722B2Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereofXIAMEN VIVOHEALTHS TECH CO LTD·Filed 2018·Granted Feb 21, 2023·1 cites·11 claims
- 2760US12410142B2Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereofXIAMEN VIVOHEALTHS TECH CO LTD·Filed 2023·Granted Sep 9, 2025·0 cites·10 claims
- 2853US2016046636A1Type ii raf kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2015·Application pending·0 cites
- 2948US2023212147A1Alkenyl pyrimidine compound, preparation method therefor, and application thereofHONGYUN BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 3048US2023310428A1Egfr inhibitor and preparation method and use thereofHONGYUN BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 3143US11542240B2STK19 inhibitors for treatment of cancerUNIV BOSTON·Filed 2019·Granted Jan 3, 2023·0 cites·24 claims
- 3242US2020325156A1Heteroaryl amide compounds, preparation method therefor, pharmaceutical compositions thereof, and applications thereofRUI JIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE·Filed 2018·Application pending·0 cites
- 3340US2021228552A1Method for adjusting ras ubiquitinationUNIV XIAMEN·Filed 2019·Application pending·0 cites
- 3436US11078213B2Thienopyrimidine compound, preparation method thereof, pharmaceutical composition and application thereofHONGYUN BIOTECH CO LTD·Filed 2017·Granted Aug 3, 2021·0 cites·13 claims
- 3536US10364247B2Preparation and use of novel protein kinase inhibitorsRUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE·Filed 2015·Granted Jul 30, 2019·0 cites·6 claims
- 3636US2022242828A1Substituted fluorine-containing imidazole salt compound, preparation method therefor, pharmaceutical composition thereof and use thereofXIAMEN VIVOHEALTHS TECH CO LTD·Filed 2020·Application pending·0 cites
- 3735US11319322B2Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereofUNIV XIAMEN·Filed 2018·Granted May 3, 2022·0 cites·12 claims
- 3823US10975092B2Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereofANHUI NEW STAR PHARMACEUTICAL DEV CO LTD·Filed 2017·Granted Apr 13, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Xianming Deng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →